- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bird Flu Risks, Myths, and Prevention Strategies: A Conversation With the NFID's Dr Robert Hopkins
Joining us for this episode of Managed Care Cast is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID), who will help separate fact from fiction about avian influenza and discuss what needs to be done to prevent a future escalation.
Welcome to Managed Care Cast, where today we’re diving into a topic that’s generating national and global concern: bird flu. Despite its rarity in humans, the virus’s alarming mortality rate—nearly 50%—raises critical questions about its severity. Why is bird flu so deadly when it does infect humans, and how do factors like preexisting conditions play a role? We'll explore these questions, as well as the risks posed by current outbreaks, how avian influenza compares with other infectious diseases, and the latest on diagnostics, treatments, and vaccine development and recommendation. Joining us is Robert H. Hopkins Jr, MD, medical director at the National Foundation for Infectious Diseases (NFID) and NFID liaison to the Advisory Committee on Immunization Practices, who will help separate fact from fiction and discuss what needs to be done to prevent a future escalation.
Listen above or through one of these podcast services:
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Infant RSV Hospitalization Rates Drop in First Season With Widespread Preventive Product Use
May 14th 2025New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the importance of timely vaccination and nirsevimab administration.
Read More
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
